SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue) announced today that, as of November 9, the U.S. Department of Health and Human Services (HHS) began deploying its molecular, ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...

Cue Health developed a rapid COVID-19 test that's become the new gold standard: fast, reliable, and easy to use. The company is now getting ready to IPO.

Cue Health, a San Diego biotech that ascended during the pandemic through mega funding and partnerships for its rapid COVID-19 test, said Wednesday that it is laying off half of its workforce as it ...

San Diego-based Cue Health, a developer of rapid molecular testing products, has raised $100M in a Series C funding round, the company said this week. The funding came from Decheng Capital, Foresite ...

The Cue Health Monitoring System has many new tests on the way, and we’re very excited about the progress and our key priority of menu expansion. We’re also happy to see the peer-review publication of ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the first quarter 2023. Recent Highlights “We reached several ...

In addition to our work on our flagship Cue Health monitoring system menu, we also expanded our Cue Integrated Care platform offerings significantly in 2023. We now offer 16 home collection test kits ...

Good day and thank you for standing by. Welcome to the Cue Health Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's ...